Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAP1B pseudogene 3 is a pseudogene sequence, meaning it is a DNA segment related to the RAP1B gene but does not produce a functional protein. The canonical gene, RAP1B, encodes a small GTPase involved in regulating cell adhesion, growth, differentiation, and signal transduction as a member of the Ras superfamily[4]. However, RAP1BP3 itself has no known biological or therapeutic function, is not classified as a receptor, enzyme, transporter, transcription factor, or any molecular family with biological activity, and is not associated with clinical targeting or disease pathology. Pseudogenes are often annotated in genomic databases, but they do not serve as drug targets or biomarkers. RAP1BP3 is occasionally listed as a genomic locus, but should not be mistaken for the canonical and functionally active RAP1B gene.\n\nIf you are interested in the functional protein RAP1B (not the pseudogene), please specify, as all relevant scientific and therapeutic data refer to the canonical RAP1B gene/protein, not RAP1BP3[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAP1B pseudogene 3 (RAP1BP3).